Macrophage Involvement in Systemic Sclerosis: Do We Need More Evidence?

被引:0
作者
Giuseppina Stifano
Romy Beatriz Christmann
机构
[1] Boston University School of Medicine,
来源
Current Rheumatology Reports | 2016年 / 18卷
关键词
Systemic sclerosis; Scleroderma; Macrophages; Monocytes; Fibrosis; Pathogenesis;
D O I
暂无
中图分类号
学科分类号
摘要
The pathogenesis of systemic sclerosis is still unknown, although immune cells, mainly macrophages/monocytes, may have an important role in initiating and/or perpetuating the disease. Macrophages and monocytes are often classified as pro-inflammatory M1 phenotype or classic activation and pro-fibrotic/anti-inflammatory M2 phenotype or alternative activation. In this review, we highlighted the most relevant research regarding the involvement of macrophages/monocytes in the pathogenesis of this complex disease.
引用
收藏
相关论文
共 250 条
[1]  
Mosser DM(2008)Exploring the full spectrum of macrophage activation Nat Rev Immunol 8 958-69
[2]  
Edwards JP(2003)Alternative activation of macrophages Nat Rev Immunol 3 23-35
[3]  
Gordon S(2011)Protective and pathogenic functions of macrophage subsets Nat Rev Immunol 11 723-37
[4]  
Murray PJ(2014)The M1 and M2 paradigm of macrophage activation: time for reassessment F1000Prime Rep 6 13-86
[5]  
Wynn TA(2015)A Hitchhiker’s guide to myeloid cell subsets: practical implementation of a novel mononuclear phagocyte classification system Front Immunol 6 406-5
[6]  
Martinez FO(2004)The chemokine system in diverse forms of macrophage activation and polarization Trends Immunol 25 677-84
[7]  
Gordon S(1987)Changes in circulating monocytes in patients with progressive systemic sclerosis J Rheumatol 14 930-20
[8]  
Guilliams M(2005)Alterations of mononuclear inflammatory cells, CD4/CD8+ T cells, interleukin 1beta, and tumour necrosis factor alpha in the bronchoalveolar lavage fluid, peripheral blood, and skin of patients with systemic sclerosis J Clin Pathol 58 178-11
[9]  
van de Laar L(2007)A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists Arthritis Rheum 56 1010-33
[10]  
Mantovani A(2010)Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis Arthritis Res Ther 12 R128-7